The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Celastrol induces ROS-mediated apoptosis via directly targeting peroxiredoxin-2 in gastric cancer cells
Open accessAbstract
Our studies have uncovered a potential Celastrol-interacting protein Prdx2 and a ROS-dependent mechanism of its action. The findings also highlight Prdx2 as a potential target for the treatment of gastric cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Sung, B., Park, B., Yadav, V. R., & Aggarwal, B. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.090209 · Cited by 123
RetractedTrott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
Comparative Protein Modelling by Satisfaction of Spatial Restraints
Šali, A., & Blundell, T. L. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1626 · Cited by 12,977
Urano, F., Wang, X., Bertolotti, A., Zhang, Y., Chung, P., Harding, H. P., & Ron, D. (2000) · Science · doi:10.1126/science.287.5453.664 · Cited by 2,988
Structure, mechanism and regulation of peroxiredoxins
Wood, Z. A., Schröder, E., Robin Harris, J., & Poole, L. B. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)00003-8 · Cited by 2,544
Guidelines for reporting experiments involving animals: the ARRIVE guidelines
McGrath, J., Drummond, G., McLachlan, E., Kilkenny, C., & Wainwright, C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00873.x · Cited by 1,592
Thiol chemistry and specificity in redox signaling
Winterbourn, C. C., & Hampton, M. B. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.05.004 · Cited by 1,226
An Endoplasmic Reticulum Stress-specific Caspase Cascade in Apoptosis
Morishima, N., Nakanishi, K., Takenouchi, H., Shibata, T., & Yasuhiko, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204973200 · Cited by 901
Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression
Neumann, C. A., Krause, D. S., Carman, C. V., Das, S., Dubey, D. P., Abraham, J. L., Bronson, R. T., Fujiwara, Y., Orkin, S. H., & Van Etten, R. A. (2003) · Nature · doi:10.1038/nature01819 · Cited by 801
Peroxiredoxin-2 and STAT3 form a redox relay for H2O2 signaling
Sobotta, M. C., Liou, W., Stöcker, S., Talwar, D., Oehler, M., Ruppert, T., Scharf, A. N. D., & Dick, T. P. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1695 · Cited by 597
Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling
Cox, A. G., Winterbourn, C. C., & Hampton, M. B. (2010) · Biochemical Journal · doi:10.1042/bj20091541 · Cited by 532
Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach
Chatterjee, S., & Burns, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091978 · Cited by 501
Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice
Lee, T.-H. (2003) · Blood · doi:10.1182/blood-2002-08-2548 · Cited by 420
Alexandre, J., Hu, Y., Lu, W., Pelicano, H., & Huang, P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3914 · Cited by 380
Rhee, S. G. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.2368 · Cited by 376
Kannaiyan, R., Shanmugam, M. K., & Sethi, G. (2011) · Cancer Letters · doi:10.1016/j.canlet.2010.10.025 · Cited by 346
PML/RARA Oxidation and Arsenic Binding Initiate the Antileukemia Response of As2O3
Jeanne, M., Lallemand-Breitenbach, V., Ferhi, O., Koken, M., Le Bras, M., Duffort, S., Peres, L., Berthier, C., Soilihi, H., Raught, B., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.06.003 · Cited by 335
Celastrol: Molecular targets of Thunder God Vine
Salminen, A., Lehtonen, M., Paimela, T., & Kaarniranta, K. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.050 · Cited by 293
Weyemi, U., Lagente-Chevallier, O., Boufraqech, M., Prenois, F., Courtin, F., Caillou, B., Talbot, M., Dardalhon, M., Al Ghuzlan, A., Bidart, J.-M., et al. (2012) · Oncogene · doi:10.1038/onc.2011.327 · Cited by 285
Li, H.-Y., Zhang, J., Sun, L.-L., Li, B.-H., Gao, H.-L., Xie, T., Zhang, N., & Ye, Z.-M. (2015) · Cell Death & Disease · doi:10.1038/cddis.2014.543 · Cited by 284
Su, X., Shen, Z., Yang, Q., Sui, F., Pu, J., Ma, J., Ma, S., Yao, D., Ji, M., & Hou, P. (2019) · Theranostics · doi:10.7150/thno.35219 · Cited by 238
Peroxiredoxins in breast carcinoma.
Karihtala, P., Mäntyniemi, A., Kang, S. W., Kinnula, V. L., & Soini, Y. (2003) · PubMed · Cited by 232
Overexpression of peroxiredoxin in human breast cancer.
Noh, D.-Y., Ahn, S. J., Lee, R., Kim, S., Park, I. A., & Chae, H. Z. (2001) · PubMed · Cited by 221
Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells
Liu, C.-X., Yin, Q.-Q., Zhou, H.-C., Wu, Y.-L., Pu, J.-X., Xia, L., Liu, W., Huang, X., Jiang, T., Wu, M.-X., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.935 · Cited by 221
Self-citationThe role of peroxiredoxins in cancer
Nicolussi, A., D'Inzeo, S., Capalbo, C., Giannini, G., & Coppa, A. (2017) · Molecular and Clinical Oncology · doi:10.3892/mco.2017.1129 · Cited by 200
ER stress induces caspase-8 activation, stimulating cytochrome c release and caspase-9 activation
Jimbo, A., Fujita, E., Kouroku, Y., Ohnishi, J., Inohara, N., Kuida, K., Sakamaki, K., Yonehara, S., & Momoi, T. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00033-2 · Cited by 189
Lim, J. C., Choi, H.-I., Park, Y. S., Nam, H. W., Woo, H. A., Kwon, K.-S., Kim, Y. S., Rhee, S. G., Kim, K., & Chae, H. Z. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804087200 · Cited by 178
Peroxiredoxins, a novel protein family in lung cancer
Lehtonen, S. T., Svensk, A., Soini, Y., Pääkkö, P., Hirvikoski, P., Kang, S. W., Säily, M., & Kinnula, V. L. (2004) · International Journal of Cancer · doi:10.1002/ijc.20294 · Cited by 173
Kannaiyan, R., Manu, K. A., Chen, L., Li, F., Rajendran, P., Subramaniam, A., Lam, P., Kumar, A. P., & Sethi, G. (2011) · Apoptosis · doi:10.1007/s10495-011-0629-6 · Cited by 170
Hou, W., Liu, B., & Xu, H. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112081 · Cited by 170
Lee, J., You, J. H., Shin, D., & Roh, J. (2020) · Theranostics · doi:10.7150/thno.46903 · Cited by 130
Peroxiredoxin I expression in human thyroid tumors
Yanagawa, T., Ishikawa, T., Ishii, T., Tabuchi, K., Iwasa, S., Bannai, S., Omura, K., Suzuki, H., & Yoshida, H. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00243-8 · Cited by 124
Glutathionylation of the Active Site Cysteines of Peroxiredoxin 2 and Recycling by Glutaredoxin
Peskin, A. V., Pace, P., Behring, J. B., Paton, L. N., Soethoudt, M., Bachschmid, M. M., & Winterbourn, C. C. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.692798 · Cited by 124
Gao, N., Rahmani, M., Dent, P., & Grant, S. (2005) · Oncogene · doi:10.1038/sj.onc.1208530 · Cited by 107
Masud, A. J., Mohapatra, A., Lakhani, S. A., Ferrandino, A. F., Hakem, R., & Flavell, R. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700077200 · Cited by 101
CPX Targeting DJ-1 Triggers ROS-induced Cell Death and Protective Autophagy in Colorectal Cancer
Zhou, J., Zhang, L., Wang, M., Zhou, L., Feng, X., Yu, L., Lan, J., Gao, W. Q., Zhang, C., Bu, Y., et al. (2019) · Theranostics · doi:10.7150/thno.34663 · Cited by 94
Lee, D. J., Kang, D. H., Choi, M., Choi, Y. J., Lee, J. Y., Park, J. H., Park, Y. J., Lee, K. W., & Kang, S. W. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4226 · Cited by 69
Shukla, K., Sonowal, H., Saxena, A., Ramana, K. V., & Sk, S. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.09.031 · Cited by 63
Expression of human peroxiredoxin isoforms in response to cervical carcinogenesis
Choe (2009) · Oncology Reports · doi:10.3892/or_00000366 · Cited by 62
Oxidative metabolism in cancer: A STAT affair?
Bourgeais, J., Gouilleux‐Gruart, V., & Gouilleux, F. (2013) · JAK-STAT · doi:10.4161/jkst.25764 · Cited by 57
Quantitative Proteomics Reveals Cellular Targets of Celastrol
Hansen, J., Palmfeldt, J., Vang, S., Corydon, T. J., Gregersen, N., & Bross, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026634 · Cited by 56
Zhao, Q. C., Ding, Y., Deng, Z., Lee, O., Gao, P., Chen, P., Rose, R., Zhao, H., Zhang, Z., Tao, X.-P., et al. (2015) · Chemical Science · doi:10.1039/c5sc00633c · Cited by 55
Celastrol induces apoptosis of gastric cancer cells by miR-146a inhibition of NF-κB activity
Sha, M., Ye, J., Zhang, L., Luan, Z., & Chen, Y.-B. (2013) · Cancer Cell International · doi:10.1186/1475-2867-13-50 · Cited by 54
Soethoudt, M., Peskin, A. V., Dickerhof, N., Paton, L. N., Pace, P., & Winterbourn, C. C. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.09.025 · Cited by 52
Synergistic effect of peroxiredoxin II antisense on cisplatin-induced cell death
Yoo, Y. D., Chung, Y. M., Park, J. K., Ahn, C. M., Kim, S. K., & Kim, H. J. (2002) · Experimental & Molecular Medicine · doi:10.1038/emm.2002.38 · Cited by 52
Shiota, M., Yokomizo, A., Kashiwagi, E., Takeuchi, A., Fujimoto, N., Uchiumi, T., & Naito, S. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.001 · Cited by 49
Adenanthin targets peroxiredoxin I/II to kill hepatocellular carcinoma cells
Hou, J.-K., Huang, Y., He, W., Yan, Z.-W., Fan, L., Liu, M.-H., Xiao, W.-L., Sun, H., & Chen, G.-Q. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.345 · Cited by 47
Park, Y.-H., Kim, S. U., Kwon, T.-H., Kim, J.-M., Song, I.-S., Hj, S., Lee, B.-K., Bang, D.-H., Lee, S., Lee, D.-S., et al. (2015) · Oncogene · doi:10.1038/onc.2015.411 · Cited by 46
Peroxiredoxin 2 is associated with colorectal cancer progression and poor survival of patients
Peng, L., Wang, R., Shang, J., Xiong, Y., & Fu, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.14801 · Cited by 43
Sun, J., Liu, X., & Li, Q. (2010) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2010.01.018 · Cited by 29
Shi, X., Ding, L., Zhou, W., Ji, Y., Wang, J., Wang, H., Ma, Y., Jiang, G., Tang, K., Ke, Y., et al. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6703 · Cited by 28
Plačková, P. (., Šála, M., Šmídková, M., Dejmek, M., Hřebabecký, H., Nencka, R., Thibaut, H. J., Neyts, J. H., & Mertlíková‐Kaiserová, H. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.06.004 · Cited by 26
Park, M. H., Yun, H., Hwang, C. J., Park, S. I., Han, S., Hwang, D. Y., Yoon, D., Kim, S., & Hong, J. T. (2017) · Theranostics · doi:10.7150/thno.21408 · Cited by 22
Cited by
Zhu, Y., Ouyang, Z., Du, H., Wang, M., Wang, J., Sun, H., Kong, L., Xu, Q., Ma, H., & Sun, Y. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.08.022 · Cited by 414
Luo, P., Liu, D., Zhang, Q., Yang, F., Wong, Y.-K., Xia, F., Zhang, J., Chen, J., Tian, Y., Yang, C., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.12.007 · Cited by 377
Metadata
- Authors
- Chen, X., Zhao, Y., Luo, W., Chen, S., Lin, F., Zhang, X., Fan, S., Shen, X., Wang, Y., & Liang, G.
- Venue
- Theranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2020
- Volume
- 10
- Issue
- 22
- Pages
- 10290-10308
- ISSN
- 1838-7640 (ISSN-L)
- OpenAlex
- W3082676535
- Cited by
- 291
- References
- 53
- FWCI
- 27.12
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.